Published in Nephrol Dial Transplant on November 29, 2007
Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol (2012) 1.90
Elimination of endogenous toxin, creatinine from blood plasma depends on albumin conformation: site specific uremic toxicity & impaired drug binding. PLoS One (2011) 0.92
Beyond muscles: The untapped potential of creatine. Int Immunopharmacol (2016) 0.83
The acute effect of beta-guanidinopropionic acid versus creatine or placebo in healthy men (ABC Trial): study protocol for a randomized controlled trial. Trials (2015) 0.76
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet (2009) 15.15
Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature (2006) 9.31
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
Acute renal failure. Lancet (2005) 5.60
On the use of scaling and clustering in the study of semantic deficits. Neuropsychology (2003) 5.38
A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Lancet Neurol (2011) 5.01
Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med (2004) 4.56
EBPG on Vascular Access. Nephrol Dial Transplant (2007) 3.26
Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol (2014) 3.06
Testing for recombinant human erythropoietin. J Appl Physiol (1985) (2008) 3.02
Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta (2006) 2.97
Hypomagnesemia and the risk of death and GFR decline in chronic kidney disease. Am J Med (2013) 2.96
The burden of kidney disease: improving global outcomes. Kidney Int (2004) 2.94
Management of crush-related injuries after disasters. N Engl J Med (2006) 2.90
Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol (2009) 2.89
Serum biomarker for progranulin-associated frontotemporal lobar degeneration. Ann Neurol (2009) 2.83
Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol (2008) 2.76
EBPG guideline on nutrition. Nephrol Dial Transplant (2007) 2.68
Acute kidney injury: an increasing global concern. Lancet (2013) 2.61
Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature. Nephrol Dial Transplant (2012) 2.59
Acute kidney injury. Lancet (2008) 2.44
The importance of standardization of creatinine in the implementation of guidelines and recommendations for CKD: implications for CKD management programmes. Nephrol Dial Transplant (2005) 2.38
FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol (2010) 2.30
Recommendation for the management of crush victims in mass disasters. Nephrol Dial Transplant (2012) 2.27
Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP). Nephrol Dial Transplant (2008) 2.24
Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro peritoneal dialysis. Nephrol Dial Transplant (2006) 2.17
Noninvasive assessment of local pulse pressure: importance of brachial-to-radial pressure amplification. Hypertension (2005) 2.15
Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrol Dial Transplant (2014) 2.10
High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy. Hum Mol Genet (2005) 2.08
Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease. Nephrol Dial Transplant (2009) 2.06
False-positive detection of recombinant human erythropoietin in urine following strenuous physical exercise. Blood (2006) 2.06
The changing epidemiology of acute renal failure. Nat Clin Pract Nephrol (2006) 2.01
Identification of 2 Loci at chromosomes 9 and 14 in a multiplex family with frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Arch Neurol (2010) 1.95
A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant (2012) 1.94
Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease. Kidney Int (2009) 1.93
Chronic kidney disease in adults--UK guidelines for identification, management and referral. Nephrol Dial Transplant (2006) 1.91
EBPG guideline on dialysis strategies. Nephrol Dial Transplant (2007) 1.90
Association of dialysate bicarbonate concentration with mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis (2013) 1.90
Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol (2012) 1.90
Educating end-stage renal disease patients on dialysis modality selection: clinical advice from the European Renal Best Practice (ERBP) Advisory Board. Nephrol Dial Transplant (2010) 1.90
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics (2010) 1.90
Cerebellar neurocognition: insights into the bottom of the brain. Clin Neurol Neurosurg (2008) 1.83
The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. Kidney Int (2004) 1.83
Complex compartmental behavior of small water-soluble uremic retention solutes: evaluation by direct measurements in plasma and erythrocytes. Am J Kidney Dis (2007) 1.77
Assessment of renal function in recently admitted critically ill patients with normal serum creatinine. Nephrol Dial Transplant (2005) 1.72
Decreased expression of the GABAA receptor in fragile X syndrome. Brain Res (2006) 1.70
Serum cystatin C concentration compared with other markers of glomerular filtration rate in the old old. J Am Geriatr Soc (2002) 1.68
Validation of a patient-specific hemodynamic computational model for surgical planning of vascular access in hemodialysis patients. Kidney Int (2013) 1.68
The personal dialysis capacity test is superior to the peritoneal equilibration test to discriminate inflammation as the cause of fast transport status in peritoneal dialysis patients. Clin J Am Soc Nephrol (2005) 1.67
Why less success of the peritoneal dialysis programmes in Europe? Nephrol Dial Transplant (2008) 1.65
EBPG guideline on haemodynamic instability. Nephrol Dial Transplant (2007) 1.65
Clinical findings in the renal victims of a catastrophic disaster: the Marmara earthquake. Nephrol Dial Transplant (2002) 1.60
SORL1 is genetically associated with increased risk for late-onset Alzheimer disease in the Belgian population. Hum Mutat (2008) 1.59
Recommendations for biomarker identification and qualification in clinical proteomics. Sci Transl Med (2010) 1.59
Clinical characteristics of patients developing ARF due to sepsis/systemic inflammatory response syndrome: results of a prospective study. Am J Kidney Dis (2004) 1.58
CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics. Proteomics Clin Appl (2008) 1.57
Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease. Am J Hum Genet (2006) 1.55
P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production. Nephrol Dial Transplant (2006) 1.53
A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats. Hum Mutat (2013) 1.53
Detection of angiotensin II in supernatants of stimulated mononuclear leukocytes by matrix-assisted laser desorption ionization time-of-flight/time-of-flight mass analysis. Hypertension (2005) 1.52
Severity of sepsis-induced acute kidney injury in a novel mouse model is age dependent. Crit Care Med (2012) 1.52
Relationship between fluid status and its management on acute renal failure (ARF) in intensive care unit (ICU) patients with sepsis: a prospective analysis. J Nephrol (2005) 1.51
Catheter-related blood stream infections (CRBSI): a European view. Nephrol Dial Transplant (2010) 1.50
Development of an affordable dye-stained microalbuminuria screening test. Nephrol Dial Transplant (2008) 1.50
Defining acute renal failure: RIFLE and beyond. Clin J Am Soc Nephrol (2006) 1.49
Acute central hemodynamic effects of a volume exchange in peritoneal dialysis. Perit Dial Int (2008) 1.49
Therapeutic interventions favorably influencing delayed and slow graft function in kidney transplantation: mission impossible? Transplantation (2008) 1.49
The effect of magnesium supplements on early post-transplantation glucose metabolism: a randomized controlled trial. Transpl Int (2014) 1.48
Acute renal failure due to crush syndrome during Marmara earthquake. Am J Kidney Dis (2002) 1.47
TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohort. Brain (2011) 1.46
Monitoring of physical activity after stroke: a systematic review of accelerometry-based measures. Arch Phys Med Rehabil (2010) 1.45
Additional value of quantitative EEG in acute anterior circulation syndrome of presumed ischemic origin. Clin Neurophysiol (2010) 1.44
CALL interrupted in a patient with non-specific mental retardation: gene dosage-dependent alteration of murine brain development and behavior. Hum Mol Genet (2003) 1.43
Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family. Arch Neurol (2007) 1.42
Initiation of dialysis--is the problem solved by NECOSAD? Nephrol Dial Transplant (2002) 1.42
Faecal leukocyte esterase activity is an alternative biomarker in inflammatory bowel disease. Clin Chem Lab Med (2015) 1.41
Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study. Clin J Am Soc Nephrol (2010) 1.40
The glomerular filtration rate in an apparently healthy population and its relation with cardiovascular mortality during 10 years. Eur Heart J (2007) 1.38
Severely altered guanidino compound levels, disturbed body weight homeostasis and impaired fertility in a mouse model of guanidinoacetate N-methyltransferase (GAMT) deficiency. Hum Mol Genet (2004) 1.37
A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD. Brain (2006) 1.36
Age-dependent cognitive decline in the APP23 model precedes amyloid deposition. Eur J Neurosci (2003) 1.36
Expression of the GABAergic system in animal models for fragile X syndrome and fragile X associated tremor/ataxia syndrome (FXTAS). Brain Res (2008) 1.35
Target haemoglobin to aim for with erythropoiesis-stimulating agents: a position statement by ERBP following publication of the Trial to reduce cardiovascular events with Aranesp therapy (TREAT) study. Nephrol Dial Transplant (2010) 1.34
The gut: the forgotten organ in uremia? Blood Purif (2010) 1.33
LIMP-2/LGP85 deficiency causes ureteric pelvic junction obstruction, deafness and peripheral neuropathy in mice. Hum Mol Genet (2003) 1.32
Neuronal inclusion protein TDP-43 has no primary genetic role in FTD and ALS. Neurobiol Aging (2008) 1.31
When to start dialysis: updated guidance following publication of the Initiating Dialysis Early and Late (IDEAL) study. Nephrol Dial Transplant (2011) 1.30
Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia. Neurobiol Aging (2013) 1.30
Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement. Nephrol Dial Transplant (2013) 1.28
Protein-bound toxins--update 2009. Semin Dial (2009) 1.28
The rise of prevalence and the fall of mortality of patients with acute renal failure: what the analysis of two databases does and does not tell us. J Am Soc Nephrol (2006) 1.25
Behavior of non-protein-bound and protein-bound uremic solutes during daily hemodialysis. Am J Kidney Dis (2002) 1.24
Effective removal of protein-bound uraemic solutes by different convective strategies: a prospective trial. Nephrol Dial Transplant (2008) 1.23
Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of Alzheimer's disease. Mol Ther (2009) 1.23
Role of symmetric dimethylarginine in vascular damage by increasing ROS via store-operated calcium influx in monocytes. Nephrol Dial Transplant (2008) 1.23
Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications. Clin Chim Acta (2008) 1.23